- Centers & Specialties
- Clinical Interests
- Neurointensive care
- Locked-in syndrome
- Brain-computer interfaces
- Restorative neurotechnology
- Medical Education
- MD, PhD, Emory University School of Medicine
- Residency, Brigham and Women's Hospital
- Board Certifications
- Vascular Neurology
- Boston: Massachusetts General Hospital
- Patient Gateway
- Yes, learn more
- Insurances Accepted
- Aetna Health Inc.
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- Cigna (PAL #'s)
- Fallon Community HealthCare
- Great-West Healthcare (formally One Health Plan)
- Harvard Pilgrim Health Plan - PBO
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- Medicare - ACD
- Neighborhood Health Plan - ACD
- Neighborhood Health Plan - PBO
- OSW - Maine
- OSW - New Hampshire
- OSW - Rhode Island
- Private Health Care Systems (PHCS)
- Railroad Medicare
- Railroad Medicare - ACD
- Senior Whole Health
- Tufts Health Plan
- United Healthcare (non-HMO) - ACD
- United Healthcare (non-HMO) - PBO
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
- Patient Age Group
Dr. Hochberg is a vascular and critical care neurologist at Massachusetts General Hospital (MGH), where he also directs the Center for Neurotechnology and Neurorecovery. In addition, he is on the Consulting Staff at Spaulding Rehabilitation Hospital; Professor of Engineering at Brown University; Senior Lecturer on Neurology at Harvard Medical School; and Director, VA RR&D Center for Neurorestoration and Neurotechnology, Providence RI. His research focuses on the translation of neurophysiology and computational neuroscience discoveries into devices to restore function for patients with neurologic disease or injury. His research has been published in journals such as Nature, the New England Journal of Medicine, Lancet, Science Translational Medicine, and the Journal of Neuroscience. As Principal Investigator and lead Clinical Investigator of the BrainGate Neural Interface System pilot clinical trials, he has earned numerous awards, including a Doris Duke Clinical Scientist Development Award, the Jospeph B. Martin Award in Basic Science, the Herbert Pardes Prize in Clinical Research, and the Derek Denny-Brown Young Neurological Scholars award. He and his BrainGate colleagues also received the Israel Brain Technologies International B.R.A.I.N. Prize, presented by President Shimon Perez. Dr. Hochberg's research has been supported by the Dept. of Veterans Affairs and the NIH, including NIDCD and the BRAIN Initiative/NINDS. Dr. Hochberg received his Sc.B. with Honors in Neural Science from Brown University in 1990. He received his MD and PhD from Emory University, where he was continued an intern in Internal Medicine. He was a resident and Chief Resident in Neurology at MGH/BWH/Harvard Medical School, where he also completed a fellowship in Stroke/Neurocritical Care in 2004.
- Research Summary
Dr. Hochberg's research focuses on the development and testing of implanted neural interfaces to help people with paralysis and other neurologic disorders. His research, which has appeared on the cover of Nature and was featured on CBS 60 Minutes, is supported by the Department of Veterans Affairs and the NIH. He is the IDE Sponsor-Investigator and principal clinical investigator of the pilot clinical trials of the BrainGate Neural Interface System.
Visit Dr. Hochberg's Research Investigator Profile for more information.
Three projects led by MGH investigators were named among the Clinical Research Forum’s Top 10 Clinical Research Achievements of 2012 at the organization’s annual meeting on April 18.
Three projects led by Massachusetts General Hospital (MGH) investigators have been named among the Clinical Research Forum's Top 10 Clinical Research Achievements of 2012.
“THIS IS ONE OF MY favorite days of the year,” said Robert Kingston, PhD, chief of MGH Molecular Biology and chair of the Executive Committee on Research (ECOR) in his welcome address at the March 20 Celebration of Science event, held in conjunction with the 66th annual meeting of the hospital’s Scientific Advisory Committee (SAC).
Nearly 15 years after a stroke left her paralyzed and unable to speak, 59-year-old Cathy Hutchinson controlled a robotic arm to lift coffee to her mouth and take a drink by thinking about moving her own arm.
An investigational implanted system being developed to translate brain signals toward control of assistive devices has allowed a woman with paralysis to accurately control a computer cursor at 2.7 years after implantation, providing a key demonstration that neural activity can be read out and converted into action for an unprecedented length of time.
Dr. Leigh Hochberg from the Department of Neurology at Massachusetts General Hospital is using neurotechnology to harness brain signals that accompany movement. The ultimate goal of the work is to "turn thought into action," with the hope of one day assisting people with ALS, spinal cord injury and stroke to regain control over their environment.
Scientists at the Massachusetts General Hospital (MGH) have initiated the BrainGate2 pilot clinical trial to expand restorative neurotechnology research for some patients with paralysis.
175 Cambridge Street
Boston, MA 02114-2743
Phone 1: 617-726-8459
Phone 2: 617-724-9247